A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years

References

• Ernster VL, Barclay J, Kerlikowske K, et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913–18.
   PubMed Web of Science ®Google Scholar
• Sørum R, Hofvind S, Skaane P, et al. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast 2010;19:499–505.
   PubMed Web of Science ®Google Scholar
• Van Steenbergen LN, Louwman AC, Coebergh JA, et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2009;115:181–3.
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish cancer register: a sample survey for year 1998. Acta Oncol Stockh Swed 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• Olsson S, Andersson I, Karlberg I, et al. Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J Med Screen 2000;7:14–18.
   PubMed Web of Science ®Google Scholar
• Silverstein MJ, Barth A, Poller DN, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer Oxf Engl 1990 1995;31A:1425–7.
   PubMed Web of Science ®Google Scholar
• Correa C, McGale P, Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monographs 2010;2010:162–77.
   PubMedGoogle Scholar
• Van Deurzen CHM, Hobbelink MGG, van Hillegersberg R, et al. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. Eur J Cancer Oxf Engl 1990 2007;43:993–1001.
   PubMed Web of Science ®Google Scholar
• http://www.swebcg.se/Files/Docs/Nationella_riktlinjer130501[1].pdf.
   Google Scholar
• Baxter NN, Virnig BA, Durham SB, et al. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004;96:443–8.
   PubMedGoogle Scholar
• Van Steenbergen LN, Voogd AC, Roukema JA, et al. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands. Breast 2014;23:63–8.
   PubMed Web of Science ®Google Scholar
• Punglia RS, Schnitt SJ, Weeks JC. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate? J Natl Cancer Inst 2013;105:1527–33.
   PubMedGoogle Scholar
• Schouten van der Velden AP, Van Dijck JAAM, Wobbes T. Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands. Eur J Surg Oncol 2007;33:424–9.
   PubMed Web of Science ®Google Scholar
• Zujewski JA, Harlan LC, Morrell DM, et al. Ductal carcinoma in situ: trends in treatment over time in the US. Breast Cancer Res Treat 2011;127:251–7.
   PubMed Web of Science ®Google Scholar
• Cutuli B, Lemanski C, Fourquet A, et al. Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French survey experience. Br J Cancer 2009;100:1048–54.
   PubMed Web of Science ®Google Scholar
• Kricker A, Armstrong B. Surgery and outcomes of ductal carcinoma in situ of the breast: a population-based study in Australia. Eur J Cancer Oxf Engl 1990 2004;40:2396–402.
   PubMed Web of Science ®Google Scholar
• Rakovitch E, Pignol J-P, Chartier C, et al. The management of ductal carcinoma in situ of the breast: a screened population-based analysis. Breast Cancer Res Treat 2007;101:335–47.
   PubMed Web of Science ®Google Scholar
• Ponti A, Lynge E, James T, et al. International variation in management of screen-detected ductal carcinoma in situ of the breast. Eur J Cancer Oxf Engl 1990 2014;50:2695–704.
   PubMed Web of Science ®Google Scholar
• Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol Stockh Swed 2006;45: 536–43.
   PubMed Web of Science ®Google Scholar
• Wärnberg F, Garmo H, Emdin S, et al. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS trial. J Clin Oncol 2014;32:3588–90.
   PubMed Web of Science ®Google Scholar
• Association of Breast Surgery at Baso 2009. Surgical guidelines for the management of breast cancer. Eur J Surg Oncol 2009;35:S1–S22.
   Web of Science ®Google Scholar
• Ananthakrishnan P, Giuliano AE. Guidelines for the use of sentinel lymph node biopsy in patients with ductal carcinoma in situ. Breast Dis Year Book Q 2007;18:238.
   Google Scholar
• Zetterlund L, Stemme S, Arnrup H, et al. Incidence of and risk factors for sentinel lymph node metastasis in patients with a postoperative diagnosis of ductal carcinoma in situ. Br J Surg 2014;101:488–94.
   PubMed Web of Science ®Google Scholar
• Coromilas EJ, Wright JD, Huang Y, et al. The influence of hospital and surgeon factors on the prevalence of axillary lymph node evaluation in ductal carcinoma in situ. JAMA Oncol 2015;1:323–32.
   PubMed Web of Science ®Google Scholar